Kedudukan dalam Saham
#33062
iXensor Co., Ltd. operates a cutting-edge technological platform that... iXensor Co., Ltd. operates a cutting-edge technological platform that transforms standard smartphones into sophisticated in vitro diagnostic (IVD) instruments, advancing the field of connected healthcare. This innovation is powered by their proprietary PixoTest technology, which intelligently leverages a smartphone's integrated lighting and image sensing modules to accurately detect and interpret color-change reactions on immunoassay or colorimetric test strips. The company's diverse product portfolio addresses various health management needs: Chronic Diseases: Solutions like the PixoTest Blood Glucose Monitoring System and PixoTest POCT System assist in managing long-term conditions. Women's Health: The Eveline Smart Fertility System and Eveline Care Telehealth Platform provide tools for fertility tracking and remote care. Infectious Diseases: Offerings such as the PixoTest COVID-19 Rapid Antigen Test facilitate rapid detection and management. Additionally, iXensor provides supporting digital infrastructure, including the PixoHealth Pass Admin app and its corresponding web portal. Established in Taipei, Taiwan, in 2012, the company is a pioneer in mobile-driven diagnostic solutions.
Perubahan (1 hari)
-2.88%
Perubahan (1 tahun)
-19.66%
Perdagangan IXensor Co., Ltd. (6734)
Hasil untuk IXensor Co., Ltd. (6734)
Hasil pada Aug 2026 TTM: 0
Menurut laporan kewangan terkini daripada IXensor Co., Ltd., hasil semasa syarikat (TTM) ialah 0. Pada tahun 2026, syarikat memperoleh hasil sebanyak 0 sama dengan hasil pada tahun 2026 iaitu 0. Hasil ialah jumlah pendapatan keseluruhan yang dijana oleh syarikat daripada jualan barangan atau perkhidmatan. Tidak seperti keuntungan, tiada perbelanjaan ditolak.
Sejarah hasil bagi IXensor Co., Ltd. dari 2026 hingga 2026
Hasil pada akhir setiap tahun
| Tahun |
Hasil |
Ubah |
|
Tidak cukup data untuk tarikh yang disediakan. |
Hasil untuk syarikat atau pesaing serupa
| Syarikat |
Hasil |
Perbezaan Hasil |
Negara |
|
|
$46.59B |
-
|
US
|
|
|
$25.84B |
-
|
US
|
|
|
$35.48B |
-
|
IE
|
|
|
$21.00B |
-
|
US
|
|
|
$6.51B |
-
|
US
|